AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 111 min read$IRTC

Blackford Quentin S. sold $3.3M of IRTC

Blackford Quentin S. (President and CEO) sold 26,859 shares of iRhythm Holdings, Inc. (IRTC) at $124.65 ($3.35M total) on 2026-08-10.

Original reporting
SEC EDGAR · Blackford Quentin S.
Published Aug 11, 2026, 8:02 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 8:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$IRTC
Neutral
medium confidence
Mentioned
$IRTC
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IRTCNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but the disclosure alone does not change the company’s operating outlook.

02

Market read

A new insider sale of roughly $3.35M was reported, which can slightly influence sentiment but lacks fundamental catalysts in the text.

03

What to watch

The article notes no 10b5-1 plan, but it still provides no stated reason for the sale, limiting inference about future performance.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-11, transaction dated 2026-08-10

Background

The article is a SEC Form 4 insider transaction disclosure for iRhythm Holdings, Inc. (IRTC).

Company-level read

Ticker impact

$IRTCNeutralMedium confidence
Context

IRTC CEO Blackford Quentin S. sold 26,859 shares in an open-market transaction for about $3.35M, per a new Form 4 filing.

Expected impact

Likely limited, short-lived impact unless paired with other negative news.

Evidence & confidence

The filing is primary-source and time-stamped, but it does not include new guidance, financial results, or a change in business outlook.

Market effects

Sector

Minimal, as this is a routine insider sale with no sector-wide signal in the text.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

The sale may be driven by diversification or pre-planned liquidity needs, so it may not reflect bearish fundamentals.

Key entities

  • issuer
    iRhythm Holdings, Inc.

    Subject of the Form 4 insider sale by its President and CEO.

  • insider
    Blackford Quentin S.

    President and CEO who sold 26,859 shares at $124.6514 on 2026-08-10.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

IRTC insider trading history →

Related articles

AUG 16
$IRTCMedAI 9/10

iRhythm (IRTC) Q2 2026 Earnings Call Transcript

iRhythm (IRTC) reported Q2 2026 revenue of $224.2M, up 20.1% YoY, with gross margin at 72.8%. GAAP net loss was $0.4M, and adjusted EBITDA was $43.3M. Full-year revenue guidance is $880M to $890M and adjusted EBITDA margin 13% to 14%. The company agreed to acquire VitalConnect for about $287.5M and received a $50M Baxter settlement.

aol.com6 min
AUG 10
$IRTCMed

Why iRhythm (IRTC) Shares Are Trading Lower Today

iRhythm Technologies (IRTC) shares fell about 2.8% after Truist cut its price target to $18 from $160, keeping a Buy rating. The move followed iRhythm’s strong Q2 results, including $224.2M revenue (+20.1% YoY) and EPS of $0.58, and a raised FY revenue guidance midpoint to $885M.

financialcontent.com4 min
AUG 10
$IRTCHighAI 9/10

iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised

iRhythm Holdings (IRTC) reported Q2 2026 adjusted EPS of 58 cents versus an adjusted loss of 32 cents a year earlier, beating the Zacks Consensus Estimate by 5900%. Revenue rose 20.1% to $224.2 million. Gross margin increased to 72.8%. Full-year 2026 revenue guidance was raised to $880 million-$890 million and adjusted EBITDA margin to 13%-14%.

tradingview.com6 min
AUG 10
$IRTCMedAI 8/10

IRTC Q2 Deep Dive: Product Portfolio Expansion and Margin Gains Highlight Quarter

iRhythm Technologies (IRTC) reported Q2 revenue of $224.2M, above analysts’ $219.2M estimate, and adjusted EPS of $0.58. Adjusted EBITDA was $43.3M versus $26.13M estimates. The company slightly raised full-year revenue guidance to $885M. It also agreed to acquire VitalConnect to expand cardiac monitoring offerings and expects margin gains from automation.

yahoo.com7 min